ATNAA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Atnaa, and when can generic versions of Atnaa launch?
Atnaa is a drug marketed by Us Army and is included in one NDA.
The generic ingredient in ATNAA is atropine; pralidoxime chloride. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine; pralidoxime chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATNAA?
- What are the global sales for ATNAA?
- What is Average Wholesale Price for ATNAA?
Summary for ATNAA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 199 |
| DailyMed Link: | ATNAA at DailyMed |
US Patents and Regulatory Information for ATNAA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Army | ATNAA | atropine; pralidoxime chloride | INJECTABLE;INTRAMUSCULAR | 021175-001 | Jan 17, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
